EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Hepatoprotective Activity of Ivabradine Against Acute Liver Injury Is Associated with Modulation of SIRT1/Nrf2, AMPK, and mTOR Signaling Pathways

Salman H. Alotaibi, Mahmoud M. Samaha, Manar Gamal, Wael M. Elsaed, Dina S. El-Agamy

Journal of Xenobiotics · 13.11.2026 · 16 (7) · 226

DOI: 10.3390/jox16070226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Xenobiotics, online erschienen am 13.11.2026. Verfasst von Salman H. Alotaibi und 4 weiteren Autor:innen. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ivabradine, an inhibitor of funny current channels, is used in the management of sinus tachycardia. This work assessed the efficacy of ivabradine as a possible prophylactic candidate for acute liver injury (ALI) in mice.

Methods

ALI was induced via acetaminophen (APAP) injection. Male Swiss Albino mice were allocated to six groups randomly, as follows: control, ivabradine control, APAP, NAC + APAP, ivabradine 10 + APAP, and ivabradine 20 + APAP. Ivabradine and NAC were given orally once daily for three successive days before the APAP challenge (with the final dose given 2 h before APAP). Different biochemical, pathological, immunohistochemical, and molecular assessments were adopted to evaluate the efficacy of ivabradine.

Results

The significant elevation of the serum liver injury markers ALT, AST, and ALP, together with the significant histopathological alterations observed in hepatic tissues, confirmed the occurrence of APAP-induced ALI. APAP induced lipid peroxidation and depleted hepatic antioxidants, which were associated with significantly restrained endogenous antioxidative defense mechanisms of the hepatocytes, such as SIRT1/Nrf2. Additionally, APAP downregulated AMPK while inducing mTOR expression. Interestingly, pretreatment with ivabradine markedly attenuated APAP-induced hepatic injury, which was associated with restoration of hepatic SIRT1 and Nrf2 expression alongside favorable modulation of AMPK/mTOR signaling, along with significant reductions in hepatic MCP-1, CD68, and caspase-3 levels.

Conclusions

Ivabradine exerts significant prophylactic hepatoprotection against APAP-provoked ALI in mice. These protective actions are associated with favorable modulation of SIRT1/Nrf2/Keap1 and AMPK/mTOR signaling alterations, though direct causal mediation remains to be confirmed via specific pathway-inhibition studies. Ivabradine may serve as a promising prophylactic candidate against drug-induced ALI.

Zitieren

APA

Alotaibi, S. H., Samaha, M. M., Gamal, M., Elsaed, W. M., & El-Agamy, D. S. (2026). Novel Hepatoprotective Activity of Ivabradine Against Acute Liver Injury Is Associated with Modulation of SIRT1/Nrf2, AMPK, and mTOR Signaling Pathways. Journal of Xenobiotics, 16(7), 226. https://doi.org/10.3390/jox16070226

Vancouver

Alotaibi SH, Samaha MM, Gamal M, Elsaed WM, El-Agamy DS. Novel Hepatoprotective Activity of Ivabradine Against Acute Liver Injury Is Associated with Modulation of SIRT1/Nrf2, AMPK, and mTOR Signaling Pathways. Journal of Xenobiotics. 2026;16(7):226. doi:10.3390/jox16070226

BibTeX
@article{Alotaibi2026,
  author = {Alotaibi, Salman H. and Samaha, Mahmoud M. and Gamal, Manar and Elsaed, Wael M. and El-Agamy, Dina S.},
  title = {Novel Hepatoprotective Activity of Ivabradine Against Acute Liver Injury Is Associated with Modulation of SIRT1/Nrf2, AMPK, and mTOR Signaling Pathways},
  journal = {Journal of Xenobiotics},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {226},
  doi = {10.3390/jox16070226}
}
Kostenlos starten →